Literature DB >> 9451031

Differential binding of lectins IL-2 and CSL to candida albicans and cancer cells.

J P Zanetta1, R Bonaly, S Maschke, G Strecker, J C Michalski.   

Abstract

The demonstration that interleukin 2 (IL-2) is a lectin specific for oligomannosides allows to understand a new function for this cytokine: as a bifunctional molecule when bound to its receptor ss, IL-2 associates the latter which the CD3/TCR complex, interacting with oligosaccharides of CD3 through its carbohydrate-recognition domain (Zanetta et al. , 1996, Biochem. J., 318, 49-53). This induces the tyrosine phosphorylation of the IL-2R beta by ++p56(lck) , the first step of the IL-2-dependent signaling. Since this specific association is disrupted in vitro by oligomannosides with five and six mannose residues, we made the hypothesis that pathogenic cells or microorganisms could bind IL-2, consequently disturbing the IL-2-dependent response. This study shows that the pathogenic yeast Candida albicans (in contrast with nonpathogenic yeasts) binds high amounts of IL-2 as did cancer cells. In contrast with cancer cells, yeasts do not bind the Man6GlcNAc2-specific lectin CSL, an endogenous "amplifier of activation signals" (Zanetta et al. , 1995, Biochem. J., 311, 629-636).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9451031     DOI: 10.1093/glycob/8.3.221

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  4 in total

Review 1.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial.

Authors:  Line Borgwardt; Nathalie Guffon; Yasmina Amraoui; Christine I Dali; Linda De Meirleir; Mercedes Gil-Campos; Bénédicte Heron; Silvia Geraci; Diego Ardigò; Federica Cattaneo; Jens Fogh; J M Hannerieke Van den Hout; Michael Beck; Simon A Jones; Anna Tylki-Szymanska; Ulla Haugsted; Allan M Lund
Journal:  J Inherit Metab Dis       Date:  2018-05-30       Impact factor: 4.982

3.  Structural differences between the putative carbohydrate-recognition domains of human IL-1 alpha, IL-1 beta and IL-1 receptor antagonist obtained by in silico modeling.

Authors:  Gérard Vergoten; Jean-Pierre Zanetta
Journal:  Glycoconj J       Date:  2007-03-06       Impact factor: 3.009

Review 4.  Alpha-mannosidosis.

Authors:  Dag Malm; Øivind Nilssen
Journal:  Orphanet J Rare Dis       Date:  2008-07-23       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.